Capablanca, Rose A.
HRN: 26-37-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/09/2025
02/15/2025
PO
1.2ml
BID
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes